A detailed history of Uni Super Management Pty LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Uni Super Management Pty LTD holds 7,389 shares of BMRN stock, worth $485,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,389
Previous 4,500 64.2%
Holding current value
$485,161
Previous $370,000 40.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$69.02 - $93.84 $199,398 - $271,103
2,889 Added 64.2%
7,389 $519,000
Q2 2024

Aug 05, 2024

BUY
$74.43 - $92.22 $133,974 - $165,996
1,800 Added 66.67%
4,500 $370,000
Q1 2024

May 13, 2024

BUY
$83.81 - $99.0 $117,334 - $138,600
1,400 Added 107.69%
2,700 $236 Million
Q2 2023

Nov 13, 2023

SELL
$86.68 - $100.3 $11.3 Million - $13.1 Million
-130,367 Reduced 99.01%
1,300 $113 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $11.4 Million - $13.2 Million
131,667 New
131,667 $11.4 Billion

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.